Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials-Reference-Cited by-同舟云学术

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Published:2009-05 Issue:9678 Volume:373 Page:1849-1860
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients;BMJ,1994

2. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002

3. Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force Recommendation Statement;Ann Intern Med,2009

4. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update;Pearson;Circulation,2002

5. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice;Heart,2005

Cited by 3074 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin use in patients with elevated lipoprotein(a): Impact on cardiovascular events and bleeding;Current Problems in Cardiology;2024-11

2. Medical Optimization of Patients with Symptomatic Peripheral Arterial Disease;Annals of Vascular Surgery;2024-10

3. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases;Metabolism;2024-10

4. Antithrombotic Therapy in Patients with Chronic Coronary Syndromes;Interventional Cardiology Clinics;2024-10

5. Percutaneous coronary angioplasty for chronic coronary syndrome: the antithrombotic therapy;Vnitřní lékařství;2024-09-04